According to the latest report by Future Market Insights on the global Bovine Lactoferrin Market, the market is expected to register a growth of 15.8% CAGR between 2023 and 2033 With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Bovine Lactoferrin Market. FMI offers insights into the …
Category Archives: Healthcare Trends
Diamond Blackfan Anemia (DBAAAS) Syndrome Therapeutics Market is expected to reach valuation of US$ 7.29 Billion by 2033
The global Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is predicted to exceed an impressive US$ 4.8 Billion in 2023, with a compound annual growth rate (CAGR) of 4.1% from 2023 to 2033. Because 90% of infected individuals develop hematologic difficulties during their first year of life, a rise in the incidence of blood disorders catapulted …
Anorectal Malformation Treatment Market to reach US$ 1,475.19 million by 2033 | FMI
According to a recent report published by Future Market Insights, the global Anorectal Malformation Treatment Market is estimated to exceed an impressive valuation of US$ 794.91 million in 2023, with a compound annual growth rate (CAGR) of 7.4% projected from 2023 to 2033. Anorectal malformations are slightly more common in boys than in girls. Anorectal …
Acrocallosal Syndrome Therapeutics Market is predicted to reach a valuation of US$ 412.4 Million by 2033 | FMI
The Global Acrocallosal Therapeutics Market is currently valued at US$ 147.9 million in 2023, with a CAGR of 10.8% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 412.4 million by 2033. Increased patient demand for treatment, as well as rising demand for improved healthcare infrastructure, promising pipeline drugs, and …
Therapeutic Drug Monitoring Market is predicted to register a CAGR of 9.7% by 2032
The therapeutic drug monitoring market is anticipated to witness an opulent growth with a phenomenal CAGR of 9.7% during the forecast period, up from US$ 1.5 Billion in 2020 to reach a valuation of US$ 2.9 Billion by 2026. Due to a reasonable surge in organ transplant surgeries, the sales of therapeutic drug monitoring are also rapidly …
Orthopedic Prosthetic Devices Market is poised to attain a CAGR of 4.7% through 2032
The orthopaedic prosthetic devices market is expected to grow at a 4.7% CAGR during the forecast period, from US$ 1.9 billion in 2019 to US$ 2.8 billion by 2027. Orthopedic Prosthetics are an external mechanical devices that replaces a missing body part in the skeletal system. Its acts as a prevention or correction of injuries …
3D Printed Surgical Models Market Size is anticipated to be US$ 1731.9 million through 2032
The 3D printed surgical models market is expected to see a prodigious CAGR of 14.7%, and is projected to increase from US$ 347.5 million in 2021 to US$ 1731.9 million by 2032. The use of 3D printed surgical models in the healthcare industry for planning tumor excision, endovascular aneurysm repair, and the treatment of trauma injuries in orthopedic surgery has improved …
Medical Billing Outsourcing Market is projected to increase at a CAGR of around 16% by 2032
The Medical Billing Outsourcing Market revenues were estimated at US$ 11.1 Billion in 2021 and is anticipated to grow at a CAGR of 16% from 2022 to 2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 55.6 Billion. To Get Sample …
Central Pain Syndrome Management Market is expected to grow most profitably in Asia Pacific | Says FMI Analyst
A recently published study by FMI expects the global Central Pain Syndrome Management Market to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the World Health Organization (WHO), the share of the world’s …
Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market is expected to reach US$ 233.05 Billion by 2033
The market for Hutchinson Gilford progeria syndrome is anticipated to reach a market value of US$ 103.07 billion in 2023 and to reach US$ 233.05 billion by 2033, at a CAGR of 8.5%. The world’s expanding population, which is also leading to an increase in progeria cases, can be blamed for the expansion of the …